case_images: PMC8195643_01
case_images: Abdominal contrast-enhanced CT upon admission. (a) Axial view; (b) Coronal view. There is splenohepatomegaly.
case_images: CRIID2021-5589739.001.jpg
case_images: PMC8195643_01_CRIID2021-5589739.001.jpg
case_images: fig1
case_images: CT revealed a splenohepatomegaly but no sign of neoplasia (Figures 1(a) and 1(b)). Cerebrospinal fluid (CSF) analysis showed lymphocyte-dominant pleocytosis with 186 nuclear cells/mm3 (180 mononuclear cells/mm3 and 6 polymorphonuclear cells/mm3) and protein concentration (41 mg/dL) and glucose concentration (96 mg/dL, with a serum glucose concentration of 140 mg/dL).
case_images: Brain MRI studies at the onset. Axial view of fluid-attenuated inversion recovery (FLAIR) images showing high-intensity lesions in the left medial temporal lobe (a), bilateral caudate nucleus, and left lentiform nucleus (b). (c), (d) MRI studies on the second day of follow-up. FLAIR images show a normal signal in the medial temporal lobe and basal ganglia and no abnormal lesion. Arrowheads indicate high-intensity lesions.
case_images: CRIID2021-5589739.002.jpg
case_images: PMC8195643_01_CRIID2021-5589739.002.jpg
case_images: fig2
case_images: Fluid-attenuated inversion recovery (FLAIR) images of brain magnetic resonance imaging (MRI) showed high-intensity lesions at the left medial temporal lobe, bilateral caudate nucleus, and left lentiform nucleus (Figures 2(a) and 2(b)). Serial FLAIR images of brain MRI showed no abnormality and the improvement of previous MRI findings (Figures 2(c) and 2(d)).
case_images: Fundus appearance on admission. There is white punctate exudate around the macula (a) and petechiae were observed (b) in the retina of the left eye. Arrowheads indicate petechiae.
case_images: CRIID2021-5589739.003.jpg
case_images: PMC8195643_01_CRIID2021-5589739.003.jpg
case_images: fig3
case_images: As fundus findings, white punctate exudate and petechiae were observed in the retina of the left eye, and a diagnosis of CMV retinitis and uveitis was made (Figures 3(a) and 3(b)).